These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 64981)

  • 21. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental studies on the combined effect of kanamycin and viomycin.
    Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):62-9. PubMed ID: 4320009
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro experiment showing that chemotherapy of tuberculosis by aminoglycoside antibiotics may influence successive chemotherapy with rifampicin].
    Tsukamura M
    Kekkaku; 1991 Jan; 66(1):13-8. PubMed ID: 1901613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
    Shimizu T
    Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 33. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
    Giorgis GE; Moschini MT; Bardessono F; Amelio M
    Minerva Med; 1981 Jun; 72(25):1581-6. PubMed ID: 6789249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 38. [The secondary sensitivity of mycobacteria].
    Hejný J; Hejná A
    Z Tuberk Erkr Thoraxorg; 1967; 126(5):303-5. PubMed ID: 4299812
    [No Abstract]   [Full Text] [Related]  

  • 39. Capreomycin and other drugs in the treatment of pulmonary tuberculosis.
    Zierski M
    Tubercle; 1969 Mar; 50():Suppl:37-9. PubMed ID: 4319132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis].
    De Stasio A; Puccini G
    Antibiotica; 1968 Dec; 6(4):358-62. PubMed ID: 4984521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.